ZA200900929B - Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same - Google Patents

Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same

Info

Publication number
ZA200900929B
ZA200900929B ZA200900929A ZA200900929A ZA200900929B ZA 200900929 B ZA200900929 B ZA 200900929B ZA 200900929 A ZA200900929 A ZA 200900929A ZA 200900929 A ZA200900929 A ZA 200900929A ZA 200900929 B ZA200900929 B ZA 200900929B
Authority
ZA
South Africa
Prior art keywords
active ingredient
pharmaceutical formulations
formulations containing
modified release
containing same
Prior art date
Application number
ZA200900929A
Inventor
Alain Constancis
You-Ping Chan
Original Assignee
Flamel Tech Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flamel Tech Sa filed Critical Flamel Tech Sa
Publication of ZA200900929B publication Critical patent/ZA200900929B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA200900929A 2006-07-28 2007-07-30 Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same ZA200900929B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0653191A FR2904219B1 (en) 2006-07-28 2006-07-28 AMPHIPHILIC COPOLYMER-BASED MICROPARTICLES AND MODIFIED RELEASE ACTIVE INGREDIENT (S) AND PHARMACEUTICAL FORMULATIONS CONTAINING SAME

Publications (1)

Publication Number Publication Date
ZA200900929B true ZA200900929B (en) 2010-06-30

Family

ID=37814390

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200900929A ZA200900929B (en) 2006-07-28 2007-07-30 Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same

Country Status (11)

Country Link
EP (1) EP2049085A1 (en)
JP (1) JP5302197B2 (en)
KR (1) KR101407033B1 (en)
CN (1) CN101568328B (en)
BR (1) BRPI0714943A2 (en)
CA (1) CA2661567C (en)
FR (1) FR2904219B1 (en)
IL (1) IL196426A (en)
MX (1) MX2009000951A (en)
WO (1) WO2008025425A1 (en)
ZA (1) ZA200900929B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2934161B1 (en) * 2008-07-28 2010-09-17 Flamel Tech Sa MICROPARTICULAR ORAL FORM USEFUL FOR THE MODIFIED RELEASE OF NANOPARTICLES.
FR2940619B1 (en) * 2008-12-31 2012-02-10 Flamel Technologies Sa COMPOSITION COMPRISING LOW OR MEDIUM AQUEOUS SOLUBILITY ASSETS
FR2954325B1 (en) 2009-12-23 2012-02-03 Flamel Tech Sa AMPHIPHILIC POLYMER FUNCTIONALIZED BY METHIONINE
JP4829351B2 (en) * 2010-02-05 2011-12-07 ナノキャリア株式会社 Easily disintegrating polymer micelle composition
CN102232932B (en) * 2010-04-27 2013-06-05 重庆莱美药业股份有限公司 Pectin-adriamycin coniuncate lyophilized preparation, and preparation method thereof
CN102657843A (en) * 2012-06-05 2012-09-12 云南民族大学 Antibacterial peptide composition and preparation method thereof
CN103483583B (en) * 2013-09-24 2015-11-18 昆明理工大学 A kind of preparation method of epsilon-polylysine
CN106163553B (en) * 2014-04-03 2021-07-23 彼昂德瓦克斯医药有限公司 Compositions of multimeric-multiepitope influenza polypeptides and production thereof
WO2016067252A1 (en) 2014-10-31 2016-05-06 Glaxosmithkline Intellectual Property Development Limited Powder formulation
KR101891715B1 (en) * 2016-01-15 2018-08-27 연세대학교 산학협력단 Nanoparticle sensitive to bioenvironment comprising poly(amino acid) for treatment of virus infection
EP3495406A4 (en) 2016-08-02 2020-04-01 Nippon Kayaku Kabushiki Kaisha Active-targeting-type polymer derivative, composition containing said polymer derivative, and uses of said polymer derivative and said composition
CN110483785B (en) * 2019-07-01 2020-05-19 中山大学 Triblock polymer, drug-loaded nano micelle, nano drug, and preparation method and application thereof
CN110343245B (en) * 2019-07-16 2021-09-28 天津大学 Glycopeptide of epsilon-polylysine-graft-hydrophobic amino acid-graft-trehalose and preparation method thereof
CN112553759A (en) * 2020-11-30 2021-03-26 福建凤竹纺织科技股份有限公司 Multifunctional alginate fiber knitted fabric

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4002736A1 (en) * 1990-01-31 1991-08-01 Hoechst Ag Poly-amino-di:carboxylic acid co-anhydro-amino-di:carboxylic derivs. - bio:degradable polymeric peptide(s) for controlled release of pharmaceuticals
US5250293A (en) * 1991-04-22 1993-10-05 Gleich Gerald J Method for the treatment of hypersensitivity diseases by administration of anionic polymers
GB9221329D0 (en) * 1992-10-10 1992-11-25 Delta Biotechnology Ltd Preparation of further diagnostic agents
DE4407898A1 (en) * 1994-03-09 1995-09-14 Hoechst Ag Nanoparticles containing an active ingredient and a polyketalic acid amide, process for their preparation and use thereof
EP2481401A1 (en) * 1999-01-18 2012-08-01 LG Life Sciences, Ltd. Lipophilic microparticles containing a protein drug or antigen and formulation comprising same
FR2814951B1 (en) * 2000-10-06 2003-01-17 Flamel Tech Sa COLLOIDAL SUSPENSION OF SUBMICRONIC PARTICLES FOR VECTORIZATION OF ACTIVE HYDROPHILIC PRINCIPLES (INSULIN) AND THEIR METHOD OF PREPARATION
WO2003035051A2 (en) * 2001-10-19 2003-05-01 Inhale Therapeutic Systems, Inc. The use of proton sequestering agents in drug formulations
FR2862541B1 (en) * 2003-11-21 2007-04-20 Flamel Tech Sa PHARMACEUTICAL FORMULATIONS FOR PROLONGED RELEASE OF INTERFERONS AND THEIR THERAPEUTIC APPLICATIONS
FR2862535B1 (en) * 2003-11-21 2007-11-23 Flamel Tech Sa PHARMACEUTICAL FORMULATIONS FOR PROLONGED RELEASE OF INTERLEUKINS AND THEIR THERAPEUTIC APPLICATIONS
FR2862536B1 (en) * 2003-11-21 2007-11-23 Flamel Tech Sa PHARMACEUTICAL FORMULATIONS FOR THE PROLONGED DELIVERY OF ACTIVE (S) PRINCIPLE (S) AND THEIR PARTICULARLY THERAPEUTIC APPLICATIONS

Also Published As

Publication number Publication date
KR20090054976A (en) 2009-06-01
FR2904219A1 (en) 2008-02-01
FR2904219B1 (en) 2010-08-13
WO2008025425A8 (en) 2009-04-16
KR101407033B1 (en) 2014-06-20
CN101568328B (en) 2012-09-05
WO2008025425A9 (en) 2008-06-12
JP5302197B2 (en) 2013-10-02
CN101568328A (en) 2009-10-28
WO2008025425A1 (en) 2008-03-06
EP2049085A1 (en) 2009-04-22
CA2661567C (en) 2016-09-20
BRPI0714943A2 (en) 2013-05-21
JP2009544759A (en) 2009-12-17
AU2007291577A1 (en) 2008-03-06
IL196426A0 (en) 2009-09-22
WO2008025425B1 (en) 2008-05-02
IL196426A (en) 2014-07-31
MX2009000951A (en) 2009-02-04
CA2661567A1 (en) 2008-03-06

Similar Documents

Publication Publication Date Title
ZA200900929B (en) Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same
IL191804A0 (en) Solid dispersion containing an active ingredient and tablets for oral administration containing the same
IL187475A (en) Oral solid dosage form comprising a first population of microparticles for the modified release of at least one analgesic active principle and a second population of microparticles containing at least one quenching agent and uses thereof
WO2008109462A3 (en) Sustained release pellets comprising wax-like material
ZA200705750B (en) Compositions and methods for stabilizing active pharmaceutical ingredients
IL183357A0 (en) Oral medicament for the modified release of at least one active principle, in multimicrocapsule form
IL188744A0 (en) High drug load formulations and dosage forms
ZA201003262B (en) Fast release solid formulation, preparation and use thereof
WO2006124047A3 (en) Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
IL193274A0 (en) Pharmaceutical formulation for aerosols, comprising two or more active agents and at least one surfactant
ZA200900335B (en) Active ingredient combinations having insecticide and acaricide properties
ZA201101477B (en) Co-crystals and pharmaceutical formulations comprising the same
IL184563A (en) Pharmaceutical foam formulations and their uses
IL181301A0 (en) Cyclopamine analogues, pharmaceutical compositions comprising them and uses thereof
EP1919288A4 (en) Medicaments containing famotidine and ibuprofen and administration of same
HK1244819A1 (en) Foxm1 peptide and medicinal agent comprising the same
IL195269A0 (en) Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
IL192206A0 (en) Topical mecamylamine formulations for ocular administration and uses thereof
EP2153831A4 (en) Anti-fatigue agent and oral composition each comprising andrographolide as active ingredient
IL195931A0 (en) Pharmaceutical preparation for oral administration with controlled active ingredient release in the small intestine and methods for its production
EP1753405A4 (en) Controlled release pharmaceutical formulation
HK1109579A1 (en) Pharmaceutical composition comprising drospirenone and ethynylestradiol
EP1753398A4 (en) Controlled release matrix pharmaceutical dosage formulation
EP1906919A4 (en) Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereof
ZA200810162B (en) Phenylphrine pulsed release formulations and pharmaceutical compositions